RELACIONES PERSONALES PROFESIONALES
4.2. RESULTADOS DE ENCUESTAS Y ENTREVISTAS
4.2.1. De los Directivos
The modest results generated from this cross-sectional study serve as motivating factors for the recommendation for further research into this line of study. A longitudinal study that is well designed to minimize limitations and eliminate confounding factors will surely generate results that will show better correlation with smoking status and degree of cigarette consumption with minimal chances of obtaining controversialresults. Therefore, to achieve the ultimate aim of using this tool in designing smoking cessation programs for individuals willing to quit smoking a longitudinal study is hereby recommended.
I will also recommend that in doubtful cases with controversialresults an assay for more tobacco-specific biomarkers, like the Tobacco-Specific Nitrosamines (eg. NNAL/NNAL-gluc), should be carried out to ascertain whether the source of serum or urine cotinine is from
xcvi cigarette smoking or dietary intake.24
By and large, my best recommendation for our youths is for them not to get recruited into cigarette smoking. More public enlightenment should therefore be embarked on by the government to save our youths and our nation from future calamity.
xcvii REFERENCES.
1. US Department of Health and Human Services. There is no risk-free level of exposure to secondhand tobacco smoke: a report of the Surgeon General.
Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health / www.treatobacco.net> page_190.
2017.
2. Scientific Committee on Tobacco and Health (SCOTH). Secondhand smoke:
review of evidence since 2008. Update of evidence on health effects of secondhand smoke.2004. http://www.smokefreeengland.co.uk.
3. Joseph KU, Ojong FE, Chibuzo CU. Peer Pressure and Tobacco Smoking among Undergraduate Students of the University of Calabar, Cross River.
Higher Education Studies. 2012; 2(3): 1925 – 4741.
4. British American Tobacco Nigeria, Mar 4,2014. – Who we are.
www.batnigeria.com>vwPagesWebLive.Accessed 25th May 2015.
5. Environmental Rights Action/Friends of the Earth Nigeria.The complete laws of Nigeria, Tobacco Smoking (Control) Act-2012. Policy and Legal Advocacy Center. http://www.nigeriatobaccocontrol.com/2011/05/?m=1.
6. Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G. Methods for quantification of exposure to cigarette smoking and environmental tobacco
xcviii
smoke: focus on developmental toxicology. Ther Drug Monit. 2009;. 31(1):
14 – 30.
7. UNDP. Nigerian’s Life Expectancy on the Rise. Human Development Report 2013 : 2 – 3.
8. Ediagbonya TF, Tobin AE. Air Pollution and Respiratory Morbidity in an Urban Area of Nigeria. Greener J of Environ ManaganPublic Safety.
2013; 2: 10 – 15.
9. Bosan IB, Okpapi JU. Respiratory Symptoms and Ventilatory Function Impairment among Wood Workers in the Savannah Belt of Northern Nigeria.
Annl of Afric J 2004; 3: 22 – 27.
10. Nwibo AN, Ugwuja EI, Nwambeke NO, Emelumadu OF, Ogbonnaya LU.
Pulmonary Problems among Quarry Workers of Stone Crushing Industrial Site at Umuoghara, Ebonyi State, Nigeria. The Int J of Occup and Environ Med, 2012; 3: 4.
11. Ibeh CC, Ele PU. Prevalence of cigarette smoking in young Nigerian females.
Afr J Med Sci.2003; 32: 335 – 338.
12. Ele PU, Ibeh CC. Influence of family and social ties on cigarette smoking in young Nigerian females. Indian J Allergy Asthma Immunol. 2001; 15(2): 97 – 101.
13. Anetor JI, Adeniyi FAA. Cadmium Status in Nigerian Cigarette Smokers.
xcix
African Journal of Biomedical Research.2000; 4: 23 – 26.
14. Anetor JI, Adeniyi FAA. Cadmium Status and the risk of bone disease in Nigerian Cigarette Smokers.Bioscience Research Communications. 2002; 14:
665 – 671.
15. Ozoh OB, Dania MG, Irusen EM. The prevalence of self-reported smoking and validation with urinary cotinine among commercial drivers in major parks inLagos, Nigeria. Journal of public health in Africa. 2014; 5(1): 316.
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5345460.
16. Bloch AB, Mowery PD, Carabalo RS. Tobacco use access and exposure to tobacco in media among middle and high school students – United States, 2004. MMWR 2005; 54: 297-300.
17. Center for Disease Control and Prevention. Nigeria : Cross River State Global Youth Tobacco Survey: Atlanta CDC, 2001.
www.ede.gov/tobacco/global/gyts/factsheets/2001/Nigeria_factsheet.html.
Accessd 28th August 2015.
18. U.S. Department of Health and Human Services (USDHHS). The Health Consequences of Smoking: Nicotine Addiction. A report of the Surgeon General,1988. U.S Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and
c
Education, Office on Smoking and Health.DHHS Publication No.(CDC) 88 – 8406, 1988.
19. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression.
J Addict Dis. 1998; 17(1): 35 – 46.
20. Mark HB, Roberts SP, Thomas VJ, Justin LK, Michael B. The Merck Manual ofDiagnosis and Therapy. 8th ed. Whitehouse Station,NJ: Merck Research Laboratories; 2006. Chapter 332,Smoking Cessation; p.2734.
21. Ralph SC, Gary AG, Terry FP, Paul DM. Factors Associated with
Discrepancies between Self-Reports on Cigarette Smoking and Measured Serum Cotinine Levels among Persons aged 17 Years or Older. Third
National Health and Nutrition Examination Survey. Am J of Epidemiol 2013;
153: 807 – 814.
22. Neal L.Benowitz, JanneHukkannen, Peyton Jacob lll. Nicotine Chemistry, Metabolism,Kinetics, and Biomarkers.HandbExp Pharmacol.2009;192:29-60.
23. National Cancer Institute (US). Risk associated with smoking cigarettes with low machine-measured yields of tar and nicotine.Smoking and Tobacco Control Monographs. US Department of Health and Human Services, National Institute of Health.2001. https://www.ncbi.nlm.nih.gov.
24. Hatsukami DK, Hecht SS, Hennrikus DJ, Joseph AM, Pentel PR. Biomarkers of tobacco exposure or harm: application to clinical and epidemiological
ci
studies. 25-26 October 2001, Minneapolis, Minnesota.Nicotine Tob Res.
2003; 5(3): 387-396.
25. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003; 3(10): 733-744.
26. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996; 18(2): 188-204.
27. Gori GB, Benowitz NL, Lynch CJ. Mouth versus deep airways absorption of nicotine in cigarette smokers. PharmacolBiochemBehav. 1986; 25(6): 1181- 1184.
28. Armitage A, Dollery C, Houseman T, Kohner E, Lewis PJ, Turner D.
Absorption of nicotine from cigars. ClinPharmacolTher. 1978; 23(2): 143- 151.
29. Benowitz NL. Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence. NIDA Res Monogr. 1990; 99: 12-29.
30. Henningfield JE, Keenan RM. Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol. 1993; 61(5): 743-750.
31. Benowitz NL, Jacob P 3rd, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther.1982; 221(2): 368-372.
32. Benowitz NL, Jacob P3rd , Hukkanen J. Individual differences in nicotine
cii
kinetics and metabolism in humans. NIDA Res Monogr.1997; 173: 48 – 64.
33. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J PharmacolExpTher. 1999; 289(3): 1545-1552.
34. Lindell G, Lunell E, Graffner H. Transdermallyadministered nicotine accumulates in gastric juice. Eur J ClinPharmacol. 1996; 51(3): 315-318.
35. Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005c; 57(1): 79-115.
36. Shigenaga MK, Trevor AJ, Castagnoli N. Metabolism-dependent covalent binding of (S)-[5-3H] nicotine to liver and lung microsomal macromolecules.
Drug MetabDispos. 1988; 16(3): 397-402.
37. Benowitz NL, Jacob P 3rd. Metabolism of nicotine to cotinine studied by a dual stable isotope method. ClinPharmacol Ther.1994; 56(5): 483-493.
38. Neurath GB, Dunger M, Orth D, Pein FG. Trans-3’-hydroxycotinine as a main metabolite in urine of smokers.Int Arch Occup Environ Health. 1987; 59(2):
199-201.
39. Feng S, Kapur S, Sarkar M, Mohammad R, Mendes P, Newland K, Roethig HJ.Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers.Toxicol.LeH. 2007;173(2):
101- 6.
ciii
40. Neurath GB. Aspects of the oxidative metabolism of nicotine. ClinInvestig.
1994; 72(3): 190-195.
41. Voncken P, Rustemeier K, Schepers G. Identification of Cis-3’-
hydroxycotinine as a urinary nicotine metabolite. Xenobiotica. 1990; 20(12):
1353-1356.
42. Bryd GD, Uhrig MS, deBethizy JD, Caldwell WS, Crooks PA, Ravard A, Riggs R. Direct determination of cotinine-N-glucuronide in urine using thermospray liquid chromatography / mass spectrometry. Biol Mass Spectrom. 1994; 23(2): 103-107.
43. Benowitz NL, Jacob P 3rd. Nicotine renal excretion rate influences nicotine intake during cigarette smoking.JPharmacolExp Ther.1985;234(1):153-155.
44. Benowitz N, Lessov-Schlaggar C, Swan G. Genetic Influences in the Variation in Renal Clearance of Nicotine and Cotinine. ClinPharmacol Ther.2008b; 84(2): 243-247.
45. Benowitz NL, Jacob P 3rd. Trans-3’-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J ClinPharmacol.
2001; 51(1): 53-59.
46. Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R.
Pharmacokinetics of nicotine in kidney failure.ClinPharmacolTher. 2000;
68(3): 250-260.
civ
47. Willes SR, Fitzgerald TK, Permutt T. Acute respiratory response to prolonged, moderate levels of tobacco smoke. J Toxicol Environ Health A 1998; 53: 193-209.
48. Bascom R, Kesavanathan J, Fitzgerald TK. Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect 1995; 103: 1026-1030.
49. Jyoti Y, Gajraj K, Rupender KR. Passive smoking affects nasal mucociliary clearance. JIACM 2014; 15(2): 96 – 9.
50. Bascom R, Kagey-Sobotka A, Proud D. Effects of intranasal capsaicin on symtoms and mediator release. J PharmacolExpTher 1991; 259: 1323-1327.
51. Blom HM, Van-Rijswuk JB, Garrelds IM, Mulder PGH, Timmermans T, Van-Wijk RG. Intranasal capsaicin is efficacious in non-allergic, non- infectious perennial rhinitis. A placebo-controlled study. Clinical and Experimental Allergy. 1997; 27(7): 796 – 801.
52. Kjellman NI. Effects of parental smoking on IgE levels in children. Lancet 1981; 1: 993-994.
53. Bradley JP, Bacharier LB, Bonfiglio J. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005; 115: e7-e14.
54. Cohen NA, Zhang S, Sharp DB. Cigarette smoke condensate inhibits
cv
transepithelial chloride transport and ciliary beat frequency. Laryngoscope 2009; 119: 2269-2274.
55. Savitski AN, Mesaros C, Blair IA. Secondhand smoke inhibits both Cl- and K+ conductances in normal human bronchial epithelial cells. Respir Res 2009;
10: 120.
56. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620.
57. Saetta M, Baraldo S, Corbino L. CD8 +ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J RespirCrit Care Med 1999; 160:
711-717.
58. Litonjua AA, Sparrow D, Guevarra L. Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study. Ann Allergy Asthma Immunol 2003; 90: 422-428.
59. Benowitz NL Brunetta PG. Smoking and cessation. In: Murray &Nadel, editor.Textbook of Respiratory Medicine.5th ed. Philadelphia. Saunders- Elsevier Publishing Inc; 2010. Pg 969.
60. “Zaria.” Ecyclopedia Britannica. Encyclopedia Britannica Inc. 07 Nov 2011.
61. History of Ahmadu Bello University. ABU Press. Chapter 10. Staff Recruitment and Development in ABU, 1962 – 1987. Pp 196 – 219.
62. Araoye OM. Research Methodology with Statistics for Health and Social
cvi
Sciences. ISBN 978 – 36450 – 80. NathadexPublishersIlorin, 2003. Pp 118.
63. WHO Report on Global Tobacco Epidemic,2009. Nigeria – Smoking Prevalence.www.who.int/tobacco/global_report/2013Accessed 28th August 2015.
64. National Youth Service Corp Decree. The NYSC Decree of 1973. Nigeria’s Constitution. Section 315, subsection 5a.
65. US Center for Disease Control and Prevention. Health behaviors of adults:
United States, 2005 – 2007.Vital and Health Statistics. 2010; Series 10, Number 245, Appendix ll, P.80.
66. Global Youth Tobacco Survey Collaborative Group. Global Youth Tobacco Survey (GYTS) : Core Questionnaire with Optional Questions, Version 1.0.
2012.
67. Alagapan R. Manual of Practical Medicine, 3rd ed. Jaypee Brothers Medical Publishers Ltd; 2007.Chapter 13, Substance Abuse; p.720.
68. Kono Biotech Co.,Ltd. Human Cotinine ELISA Kit. Catalogue Number: KN 1406Hu. www.konobiotech.com. Accessed July 2017.
69. Anthony SF, Eugene B, Dennis LK, Stephen LH. Harrison’s Manual of Medicine, 17th ed. McGraw Hill Medical; 2009. Chapter 57, Azotemia and Urinary Abnormalities; p.276.
70. Vartiainen E, Seppala T, Lillsunde P, Puska P. Validation of self reported
cvii
smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health.2002; 56: 167-170.
71. Moyer TP, Charlson JR, Enger RJ. Nicotine and Metabolites, urine-NICOU:
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. ClinChem 2002; 48: 1460-1471.
72. Janet LP, Philip JP: Diagnostic Studies. Oxford Handbook of Medical Statistics. 2013; 9: 339 – 351.
73. Kevin L, Staff W. Filtered and Unfiltered Cigarettes – Similarities and Dissimilarities. http//tobaccopub.net/tobacco-info 2012. Accessed 25th June 2017.
74. Collins LC, Walker J, Stamford BA. Smoking multiple high – versus Low – nicotine cigarettes: impact on resting energy expenditure. PubMed1996;
45(8): 923 – 6.
75. Emerole CAJ, Chineke HN, Diwe KC, Onubeze DPM. The prevalence of smoking among undergraduates of Imo State University Owerri, South- -Eastern Nigeria. Nigerian Journal of General Practice. 2013; 11(2): 52.
https://www.ajol.info/index.php/njgp/article/view/97978.
76. US Department of Health and Human Services. Preventing Tobacco Use Among Youth and Young Adults: A report of the Surgeon General.
cviii
Atlanta,G.A: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2012.
https://www.ncbi.nlm.nih.gov/books/NBK99237.
77. MiYang J, HyeonCheol J, KyoungSoon L, JongFun Y. The acute effect of smoking a single cigarette on vascular status, SPO2 and stress level. Med Sci Monit. 2014; 20: 601 – 607.
78. Igor ACdM, Marcio RVS, Claudio LPdC. Evaluation of endothelial function on atherosclerosis using perfusion index from pulse oximeter. ArqBras Cardiol. 2014; 102(3): 237 – 244.
79. Salamatu UA, Abubakar SC, Abdurrahman MJ, Fatima KG. Prevalence of physical inactivity, hypertension, obesity and tobacco smoking: A case of NCDs Prevention among adults in Maiduguri, Nigeria. American Journal of Medical Sciences and Medicine. 2015; 3(4): 39 – 47.
80. Groppelli A, Giorgi DM, Omboni S, Porati G, Mancia G. Persistent blood pressure increaseinduced by heavy smoking. J Hypertens. 1992; 10: 495 – 9.
https://www.ncbi.nlm.nih.gov/pubmed/1317911.
81. Marcos GM, Marisa CMA, Sonia PCF. Twenty-four hour blood pressure record for smokers and nonsmokers. Arq. Bras. Cardiol. Sao Paulo.2006;
87(4).
http://www.scielo.br/scielo.php?pid=S0066-cix
782X2006001700016&script=sci_arttext&ting=en.
82. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Pubmed Hypertension 2001; 37(2): 187 – 93.
https://www.ncbi.nlm.nih.gov/pubmed/11230269.
83. Wannamethee SG, Shaper AG. Cigarette smoking and serum liver enzymes:
the role of alcohol and inflammation. Ann ClinBiochem. 2010; 47(4): 321– 6 84. Emad-Aldin IO, Abdullah AD, Waleed HO and Gamal ME. Effects of
cigarette smoking on blood sodium and potassium levels in Sudanese subjects.
IntJourn of Pharma and Bio Sciences. 2011; 2(3): 75 – 79.
https://www.ncbi.nlm.nih.gov/pubmed/609324.
85. Munzir MEA, Al-Obosi SAJ, Osman HM, Shayoub ME. The effect of smoking cigarette on kidney functions among Sundaes peoples. International Journal of Development Research. 2015; 5(05): 4473 – 4475.
86. Halimi JM, Giraudeau B. Effects of current smoking and smoking
discontinuation on renal function and proteinuria in the general population.
Kidney int.2000; 58(3): 1285 – 92.
87. Iya-EzeBassey, AlphonsusEUdoh. Serum Vitamin A, E, C and Catalase in Active and Passive Smokers in Nigeria. Asia-Pac J ClinOncol 2014; 10(8):
172 – 173.
cx
88. Niima B, Masoud S, Ebrahim A, Jafar B, Reza D, Reza M, Mohammad HG.
Correlation between cigarette smoking and urine cotinine level in gastric cancer patients. Iran J Pharm Res. Winter 2014; 13(1): 313 – 318.
89. Daniel OS, Mark H, Anna HW. Is residual confounding a reasonable explanation for the apparent protective effects of beta-carotene found in epidemiologic studies of lung cancer in smokers.Ame J of Epidemiol. 2001;
121 (3): 74.
90. Domino EF. The nicotine content of common vegetables. New Engl J Med.
1993; 329 – 437.
91. Domino EF, Hariharam M, VanNoord T, Demana T. Current experience with HPLC and GC-MS analyses of nicotine and cotinine. Med Sci Res. 1992; 20:
859 – 860.
92. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, Jacobs DR. Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. American Journal of Public Health. 1990; 80(9):1053 – 6.
93. Gan WQ, Cohen SB, Man SF, Sin DD. “Sex-related differences in serum cotinine concentrations in daily cigarette smokers.” . Nicotine and tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2008; 10(8): 1293 – 300.
cxi
94. Zhu AZX, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race and sex. Cancer Epidemiol Biomarkers Prev. 2013; 22(4): 708 – 718.
95. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y.
Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987; 77(11): 1435 – 1438.
96. Mitali R, Aarti G, Pramod Y, Kunal J and Sahil H. Diagnostic Methods for Detection of Cotinine Levels in Tobacco Users. J ClinDiagn Res. 2016;10(3).
ZE04 – ZE06. https//europepmc.org/articles/pmc4843405.
97. Fagerstrom Test for Nicotine Dependence.
ndri.curtin.edu.au/btitp/documents/Fagerstrom_test.pdf. Accessed 14th
October 2015.
98. Shapiro SD, Reilly JJ, Rennard SI.Chronic bronchitis and emphysema. In:
Murray and Nadel, editor. Textbook of Respiratory Medicine.5th ed.
Philadelphia.Saunders-Elsevier Publishing Inc; 2010. Pg 944.
99. Murray L, Ian BW, Tom T, Chee KC. Kidney Function: Estimating GFR. In:
Murray L, Ian BW, Andrew B and Elizabeth W, editors.Oxford Handbook of Clinical Medicine. 7th ed. New York.Oxford University Press. 2007. Pg 660 – 661.
cxii APPENDIX l